Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
about
LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectivesModelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreHolocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effectsLRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection.Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration.Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
P2860
Q28078899-CD9D0B6B-9310-4F78-918F-5195C97AA849Q29048624-F8B12F47-CAD7-420B-ADC2-D62AF5F4133DQ33734084-3D9FD062-81A2-4C4A-B4C9-203692FD3FF3Q39137339-5545A1C3-FA2E-460D-B68D-8642DBF3F39EQ39392775-F4C719CB-A235-40E1-80BD-DC084C871D22Q40087652-10BF9C8A-D6EC-4DE2-B9E0-E5441CADBFB9Q48350333-1336D1B8-B230-4D76-B9E2-B0BC357E90DDQ49886566-50D71F4C-45FD-4D52-A13E-DEB7AB87D4BCQ55420860-699F2E72-5AB2-4F35-9AA0-00EC37F36790Q58111473-660EB059-2CD0-4DE6-8CE5-D207B21B33AC
P2860
Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@en
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@nl
type
label
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@en
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@nl
prefLabel
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@en
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@nl
P2860
P50
P356
P1433
P1476
Increased peripheral inflammat ...... at kinase 2 mutation carriers.
@en
P2860
P304
P356
10.1002/MDS.26529
P407
P577
2016-02-25T00:00:00Z